Contact Us
Celiac Disease Treatment Global Market Report 2025
Global Celiac Disease Treatment Market Report 2025
Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Celiac Disease Treatment Global Market Report 2025

By Treatment Type (Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments ), By Enzyme Type (Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue ), By Diagnosis (Serological Tests, Genetic Testing, Biopsy), By Distribution Channel (Hospitals, Research Centres, Clinics, Other Distribution Channels) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Celiac Disease Treatment Market Overview

• Celiac Disease Treatment market size has reached to $0.61 billion in 2024

• Expected to grow to $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%

• Growth Driver: Rise In Prevalence Of Diabetes Fueling The Growth Of The Market Due To Shared Autoimmune Links And Dietary Management Needs

• Market Trend: Innovative Oral Therapies Targeting Immune Response And Gut Health

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Celiac Disease Treatment Market?

Celiac disease treatment involves managing the Celiac disease, an autoimmune reaction to gluten that damages the small intestine and impairs nutrient absorption by following a strict gluten-free diet. It avoids foods and products containing wheat, barley, rye, and other gluten-containing grains. Celiac disease treatment reduces symptoms, heals the lining of the small intestine, and prevents long-term health issues.

The main types of treatment for celiac disease are vitamins and minerals, gluten-degrading enzymes, symptomatic treatments, and others. Vitamins and minerals are essential micronutrients required in small amounts to support key bodily functions such as immune response, energy production, and bone health. Enzyme therapies target symptoms such as distension, diarrhea, anorexia, bloating, gas, and fatigue. Diagnostic methods used for celiac disease include serological tests, genetic testing, and intestinal biopsy. Treatment and diagnostic services are delivered through various distribution channels, including hospitals, research centers, clinics, and others.

Celiac Disease Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Celiac Disease Treatment Market Size 2025 And Growth Rate?

The celiac disease treatment market size has grown strongly in recent years. It will grow from $0.61 billion in 2024 to $0.66 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in prevalence of celiac disease, increase in awareness and diagnosis rates, growth in demand for non-dietary treatment options, strong pipeline of innovative therapies, supportive regulatory initiatives, and increase in investment from pharmaceutical companies.

What Is The Celiac Disease Treatment Market Growth Forecast?

The celiac disease treatment market size is expected to see strong growth in the next few years. It will grow to $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising global prevalence of celiac disease, increasing awareness and diagnosis rates, ongoing clinical trials for novel treatments, growing demand for gluten-free alternatives, supportive regulatory initiatives for orphan diseases, and rising healthcare expenditure. Major trends in the forecast period include adoption of novel non-dietary therapies, advancements in enzyme supplements, personalized medicine approaches, development of peptide-based immunotherapies, improved diagnostic tools, and advancements in clinical trials.

The forecast of 9.3% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. gastroenterology practices by inflating prices of gluten-free enzyme supplements manufactured in Italy and Canada, resulting in limited celiac management options and higher digestive health care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Celiac Disease Treatment Market Segmented?

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, vitamin d, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

What Is Driving The Celiac Disease Treatment Market? Rise In Prevalence Of Diabetes Fueling The Growth Of The Market Due To Shared Autoimmune Links And Dietary Management Needs

The rise in the prevalence of diabetes is expected to propel the growth of the celiac disease treatment market going forward. Diabetes is a chronic medical condition where the body is unable to regulate blood sugar or glucose levels properly. The increasing prevalence of diabetes is due to shared dietary management needs, as both diabetes and celiac disease require careful control of food intake to manage blood sugar levels and prevent complications. Celiac disease treatment aids diabetes by promoting a gluten-free diet, which can help improve overall digestive health and nutrient absorption. It supports better blood sugar control and reduces complications in individuals managing both conditions. For instance, in June 2024, according to the National Health Service, a UK-based government department, around 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the rise in the prevalence of diabetes is driving the growth of the celiac disease treatment industry.

Who Are The Major Players In The Global Celiac Disease Treatment Market?

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX

What Are The Key Trends Of The Global Celiac Disease Treatment Market? Innovative Oral Therapies Targeting Immune Response And Gut Health

Major companies operating in the celiac disease treatment market are focusing on developing oral therapies, such as small molecule therapies, to provide targeted relief by blocking immune responses to gluten, improving patient adherence, and offering alternatives to strict gluten-free diets. Small molecule therapies are tiny drugs that enter cells easily to target and treat disease-causing proteins or enzymes. For instance, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that increases endogenous glucagon-like peptide-1 (GLP-1) levels, which helps improve intestinal barrier function in celiac disease patients. It also enhance nutrient absorption and alleviate symptoms without suppressing immune activity.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Celiac Disease Treatment Market? Takeda, Zedira, And Dr. Falk Pharma Collaborated To Advance Celiac Disease Therapy

In October 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, partnered with Zedira GmbH and Dr. Falk Pharma. The partnership aims to develop TAK-227 (ZED1227), an oral therapy for celiac disease that targets intestinal repair and inflammation, offering a potential new treatment option. Zedira GmbH is a Germany-based biotechnology company specializes in providing treatment for celiac disease and other transglutaminase-linked conditions. Dr. Falk Pharma is a Germany-based pharmaceutical company specializes in developing medicines to treat gastrointestinal disorders.

What Is The Regional Outlook For The Global Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Celiac Disease Treatment Market?

The celiac disease treatment market consists of sales of gluten-free food products, vitamin D, Vitamin B12, and folic acid supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Celiac Disease Treatment Industry?

The celiac disease treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the celiac disease treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Celiac Disease Treatment Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $0.66 billion
Revenue Forecast In 2034 $0.94 billion
Growth Rate CAGR of 9.3% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Celiac Disease Treatment Market Characteristics

3. Celiac Disease Treatment Market Trends And Strategies

4. Celiac Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Celiac Disease Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Celiac Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Celiac Disease Treatment Market Growth Rate Analysis

5.4. Global Celiac Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Celiac Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Celiac Disease Treatment Total Addressable Market (TAM)

6. Celiac Disease Treatment Market Segmentation

6.1. Global Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Vitamins And Minerals

Gluten Degrading Enzymes

Symptomatic Treatment

Other Treatments

6.2. Global Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Distension

Diarrhea

Anorexia

Bloating

Gas

Fatigue

6.3. Global Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Serological Tests

Genetic Testing

Biopsy

6.4. Global Celiac Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Research Centers

Clinics

Other Distribution Channels

6.5. Global Celiac Disease Treatment Market, Sub-Segmentation Of Vitamins And Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Iron Supplements

Calcium Supplements

Vitamin D

Vitamin B12

Multivitamins

6.6. Global Celiac Disease Treatment Market, Sub-Segmentation Of Gluten Degrading Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Endopeptidases

Exopeptidases

Combination Enzyme Formulations

6.7. Global Celiac Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antidiarrheal Medications

Antidepressants

Anti-inflammatory Drugs

Immunosuppressive Agents

6.8. Global Celiac Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Probiotics

Immunotherapy

Stem Cell Therapy

Experimental Therapies

7. Celiac Disease Treatment Market Regional And Country Analysis

7.1. Global Celiac Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Celiac Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Celiac Disease Treatment Market

8.1. Asia-Pacific Celiac Disease Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Celiac Disease Treatment Market

9.1. China Celiac Disease Treatment Market Overview

9.2. China Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Celiac Disease Treatment Market

10.1. India Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Celiac Disease Treatment Market

11.1. Japan Celiac Disease Treatment Market Overview

11.2. Japan Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Celiac Disease Treatment Market

12.1. Australia Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Celiac Disease Treatment Market

13.1. Indonesia Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Celiac Disease Treatment Market

14.1. South Korea Celiac Disease Treatment Market Overview

14.2. South Korea Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Celiac Disease Treatment Market

15.1. Western Europe Celiac Disease Treatment Market Overview

15.2. Western Europe Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Celiac Disease Treatment Market

16.1. UK Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Celiac Disease Treatment Market

17.1. Germany Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Celiac Disease Treatment Market

18.1. France Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Celiac Disease Treatment Market

19.1. Italy Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Celiac Disease Treatment Market

20.1. Spain Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Celiac Disease Treatment Market

21.1. Eastern Europe Celiac Disease Treatment Market Overview

21.2. Eastern Europe Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Celiac Disease Treatment Market

22.1. Russia Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Celiac Disease Treatment Market

23.1. North America Celiac Disease Treatment Market Overview

23.2. North America Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Celiac Disease Treatment Market

24.1. USA Celiac Disease Treatment Market Overview

24.2. USA Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Celiac Disease Treatment Market

25.1. Canada Celiac Disease Treatment Market Overview

25.2. Canada Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Celiac Disease Treatment Market

26.1. South America Celiac Disease Treatment Market Overview

26.2. South America Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Celiac Disease Treatment Market

27.1. Brazil Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Celiac Disease Treatment Market

28.1. Middle East Celiac Disease Treatment Market Overview

28.2. Middle East Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Celiac Disease Treatment Market

29.1. Africa Celiac Disease Treatment Market Overview

29.2. Africa Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Celiac Disease Treatment Market Competitive Landscape And Company Profiles

30.1. Celiac Disease Treatment Market Competitive Landscape

30.2. Celiac Disease Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Celiac Disease Treatment Market Other Major And Innovative Companies

31.1. Novartis AG

31.2. Takeda Pharmaceuticals Company Ltd.

31.3. Amgen Inc.

31.4. General Mills Inc.

31.5. Viatris Inc.

31.6. Teva Pharmaceutical Inc.

31.7. Nestlé Health Science

31.8. Hikma Pharmaceuticals PLC

31.9. Amneal Pharmaceuticals LLC

31.10. Zydus Pharmaceuticals Inc.

31.11. Glenmark Pharmaceuticals Company Ltd.

31.12. West-Ward Pharmaceuticals Company Ltd

31.13. Innovate Biopharmaceutical

31.14. Acto Biosciences

31.15. ImmunogenX

32. Global Celiac Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Celiac Disease Treatment Market

34. Recent Developments In The Celiac Disease Treatment Market

35. Celiac Disease Treatment Market High Potential Countries, Segments and Strategies

35.1 Celiac Disease Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Celiac Disease Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Celiac Disease Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Celiac Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Celiac Disease Treatment Market, Sub-Segmentation Of Vitamins And Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Celiac Disease Treatment Market, Sub-Segmentation Of Gluten Degrading Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Celiac Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Celiac Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Celiac Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Celiac Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Pfizer Inc. Financial Performance
  • Table 80: Johnson And Johnson Financial Performance
  • Table 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 82: Merck And Co. Inc. Financial Performance
  • Table 83: Sanofi S.A. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Celiac Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Celiac Disease Treatment Market, Sub-Segmentation Of Vitamins And Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Celiac Disease Treatment Market, Sub-Segmentation Of Gluten Degrading Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Celiac Disease Treatment Market, Sub-Segmentation Of Symptomatic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Celiac Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Celiac Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Celiac Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Celiac Disease Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Celiac Disease Treatment Market, Segmentation By Enzyme Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Celiac Disease Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Pfizer Inc. Financial Performance
  • Figure 80: Johnson And Johnson Financial Performance
  • Figure 81: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 82: Merck And Co. Inc. Financial Performance
  • Figure 83: Sanofi S.A. Financial Performance

Frequently Asked Questions

Celiac disease treatment involves managing the Celiac disease, an autoimmune reaction to gluten that damages the small intestine and impairs nutrient absorption by following a strict gluten-free diet. It avoids foods and products containing wheat, barley, rye, and other gluten-containing grains. Celiac disease treatment reduces symptoms, heals the lining of the small intestine, and prevents long-term health issues. For further insights on this market, request a sample here

The market major growth driver - Rise In Prevalence Of Diabetes Fueling The Growth Of The Market Due To Shared Autoimmune Links And Dietary Management Needs. For further insights on this market, request a sample here

The celiac disease treatment market size has grown strongly in recent years. It will grow from $0.61 billion in 2024 to $0.66 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise in prevalence of celiac disease, increase in awareness and diagnosis rates, growth in demand for non-dietary treatment options, strong pipeline of innovative therapies, supportive regulatory initiatives, and increase in investment from pharmaceutical companies. The celiac disease treatment market size is expected to see strong growth in the next few years. It will grow to " $0.94 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising global prevalence of celiac disease, increasing awareness and diagnosis rates, ongoing clinical trials for novel treatments, growing demand for gluten-free alternatives, supportive regulatory initiatives for orphan diseases, and rising healthcare expenditure. Major trends in the forecast period include adoption of novel non-dietary therapies, advancements in enzyme supplements, personalized medicine approaches, development of peptide-based immunotherapies, improved diagnostic tools, and advancements in clinical trials. For further insights on this market, request a sample here

The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies For further insights on this market,
request a sample here

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX . For further insights on this market, request a sample here.

Major trends in this market include Innovative Oral Therapies Targeting Immune Response And Gut Health. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon